Ads
-
Related paper
- Effect of Atorvastatin on Clinical Manifestations and Outcomes in Patients with COVID-19
- COVID-19 clinical outcomes and risk factors in fully vaccinated hemodialysis patients: A single-center prospective cohort study
- High-density lipoproteins and clinical outcomes of COVID-19 in hemodialysis patients: A multicenter, propensity-score matched case-control study
- A STUDY OF OCULAR MANIFESTATIONS AMONG COVID-19 AND POST COVID PATIENTS ATTENDING A TEACHING HOSPITAL, VISHAKAPATNAM
- CLINICAL AND ANTI-INFLAMMATORY EFFECTIVENESS OF COMPLEX TREATMENT WITH ATORVASTATIN IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- Potential additive effects of garcinia cambogia on atorvastatin treated hyperlipidemic patients: randomized crossover clinical study
- COMPARE CHARACTERISTIC OF CLINICAL STATE AND INDEX OF LIPID SPECTRUM DYNAMICS IN PATIENTS WITHOUT AND AFTER AORTIC-CORONARY BYPASS DURING THE STAGES OF ATORVASTATIN THERAPY
- Gastrointestinal and Liver Manifestations in Patients with COVID-19
- Respiratory Manifestations and Outcome of COVID-19 Positive Patients with CKD
- Distinctive COVID-19 manifestations and re-exposure to SARS CoV 2 in clinical laboratory personnel under regular monitoring by RT-PCR and serology